Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators (Q73480497)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2000

Language	Label	Description	Also known as
English	Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators	scientific article published on 01 March 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

cigarette smoking

1 reference

based on heuristic

inferred from title

acute coronary syndrome

1 reference

based on heuristic

inferred from title

4

object named as

E J Topol

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2019

5

object named as

R M Califf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

D Hasdai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D R Holmes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D A Criger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R G Wilcox

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Paolasso

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Simoons

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Deckers

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R A Harrington

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

454-460

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Relative effects of cigarette smoke and ethanol on acute platelet thrombus formation in stenosed canine coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Thrombosis in Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Antiplatelet drugs. A comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Epinephrine potentiation of in viw stimuli reverses aspirin inhibition of platelet thrombos formation in stenosed canine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990089-9

7 January 2021

Identifiers

10.1016/S0002-8703(00)90089-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10689260%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73480497&oldid=2224886693"